Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.38 |
| ▸ | MMP13 | P45452 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Perflenapent SCHEMBL7648533 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL984715 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL3743142 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1924377 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| Perflexane SCHEMBL3671912 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| Perflexane SCHEMBL7507426 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1779065 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL771546 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| Perflexane SCHEMBL20769778 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 | |
| Perflenapent SCHEMBL33962 | 1.00 | LMNA (0.61) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4555000-A2 | PRODUCT FOR PFAS ADSORPTION | Active Minerals International, LLC (US) | 2025-05-21 | — | — | EP | disclosed |
| CN-119775703-A | Polymer composition and guided self-assembly method of film thereof | 中国科学院长春应用化学研究所 | 2025-04-08 | — | — | CN | disclosed |
| CN-119639164-A | Block copolymer composition and guided self-assembly method of film thereof | 中国科学院长春应用化学研究所 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024015224-A2 | PRODUCT FOR PFAS ADSORPTION | ACTIVE MINERALS INTERNATIONAL, LLC (US) | 2024-01-18 | — | — | WO | disclosed |
| EP-4302753-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | The University of Tokyo (JP) | 2024-01-10 | — | — | EP | disclosed |
| US-20230404065-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | THE UNIVERSITY OF TOKYO (JP) | 2023-12-21 | — | — | US | disclosed |
| CN-108793770-B | Scratch-resistant hydrophobic glass and preparation method thereof | 中建材玻璃新材料研究院集团有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116917029-A | Microparticles and microparticle dispersions | 国立大学法人东京大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-115487305-A | Liquid composition for delivering active pharmaceutical ingredients | 江苏君隽生物科技有限公司 | 2022-12-20 | — | — | CN | disclosed |
| WO-2022186224-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | 国立大学法人 東京大学 | 2022-09-09 | — | — | WO | disclosed |
| EP-1974013-A2 | IMPROVED COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | Anthrogenesis Corporation (US) | 2008-10-01 | — | — | EP | disclosed |
| US-20070190042-A1 | Composition for collecting and preserving placental stem cells and methods of using the composition | Celularity, Inc. | 2007-08-16 | — | — | US | disclosed |
| WO-2007079185-A2 | IMPROVED COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | ANTHROGENESIS CORPORATION (US) | 2007-07-12 | — | — | WO | disclosed |
| EP-1764391-A1 | POLYOL-CROSSLINKABLE FLUORORUBBER COMPOSITION | NOK Corporation (JP) | 2007-03-21 | — | — | EP | disclosed |
| US-6468502-B1 | PARAMAGNETIC MACROMOLECULES WITH HIGHER PROTON RELAXIVITY; LOWER DOSAGE AND INCREASED SIGNAL INTENSITY; DETECTING VASCULAR DISEASES; DIFFERENTIATING TISSUE BLOOD SUPPLY LEVELS; DISTINGUISHING MYOCARDIAL INFARCTION FROM ISCHEMIA | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-10-22 | — | — | US | disclosed |
| US-6461782-B1 | TONER, WHICH COMPRISES TONER BINDER AND COLORANT, HAVING SPECIFIED GLASS TRANSITION POINT BEFORE CURING; BINDER BEING COMPOSED OF RESIN INCLUDING CATION-POLYMERIZABLE THERMOPLASTIC RESIN HAVING PROPENYL ETHER GROUP | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2002-10-08 | — | — | US | disclosed |
| EP-0882010-A1 | PHARMACEUTICAL AGENTS CONTAINING PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THE USE THEREOF IN TUMOUR THERAPY AND INTERVENTIONAL RADIOLOGY | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-12-09 | — | — | EP | disclosed |
| EP-0874645-A2 | PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THEIR USE IN NMR DIAGNOSTICS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997030969-A1 | PHARMACEUTICAL AGENTS CONTAINING PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THE USE THEREOF IN TUMOUR THERAPY AND INTERVENTIONAL RADIOLOGY | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-08-28 | — | — | WO | disclosed |
| WO-1997026017-A2 | PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THEIR USE IN NMR DIAGNOSTICS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070190042-A1 | Composition for collecting and preserving placental stem cells and methods of using the composition | PGF, ALPP, CPA1 | LMNA 1146/4885THRB 4772/4885CA2 217/4885 |
| US-20230404065-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | CHMP4B, FGB, PFAS | LMNA 697/4885THRB 2147/4885CA2 4869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.